These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20541902)

  • 21. Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl.
    Praharaj SK; Sarkhel S; Khanande RV; Sinha VK
    Psychopharmacol Bull; 2010; 43(4):73-5. PubMed ID: 21240153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual Atropine Sulfate Use for Sialorrhea in Pediatric Patients.
    Azapağası E; Kendirli T; Perk O; Kutluk G; Öz Tunçer G; Teber S; Çobanoğlu N
    J Pediatr Intensive Care; 2020 Sep; 9(3):196-200. PubMed ID: 32685247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series.
    Freudenreich O; Beebe M; Goff DC
    J Clin Psychopharmacol; 2004 Feb; 24(1):98-100. PubMed ID: 14709958
    [No Abstract]   [Full Text] [Related]  

  • 25. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
    Boyce HW; Bakheet MR
    J Clin Gastroenterol; 2005 Feb; 39(2):89-97. PubMed ID: 15681902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atropine eyedrops for death rattle in a terminal cancer patient.
    Shinjo T; Okada M
    J Palliat Med; 2013 Feb; 16(2):212-3. PubMed ID: 22747099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis.
    Yellepeddi VK; Race JA; McFarland MM; Constance JE; Fanaeian E; Murphy NA
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):267-277. PubMed ID: 38577753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers.
    Parrot M; Yathavan B; Averin O; Hoggard L; Rower JE; Voight M; Greene D; Tarrell A; Whelan A; Ghandehari H; Murphy N; Yellepeddi V
    Clin Transl Sci; 2024 Mar; 17(3):e13753. PubMed ID: 38465519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease.
    Thomsen TR; Galpern WR; Asante A; Arenovich T; Fox SH
    Mov Disord; 2007 Nov; 22(15):2268-73. PubMed ID: 17876852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease.
    Farber NM; Perez-Lloret S; Gamzu ER
    Curr Top Med Chem; 2015; 15(10):939-54. PubMed ID: 25832720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of atropine eye drops for clozapine induced hypersalivation.
    Comley C; Galletly C; Ash D
    Aust N Z J Psychiatry; 2000 Dec; 34(6):1033-4. PubMed ID: 11127617
    [No Abstract]   [Full Text] [Related]  

  • 33. In brief: Glycopyrrolate oral solution for sialorrhea.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical atropine sulfate for the treatment of axillary hyperhidrosis.
    Grimalt R; Domínguez Tordera P; Callejas MA
    J Cosmet Dermatol; 2006 Dec; 5(4):294-6. PubMed ID: 17716247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
    Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
    J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Premedication with non-selective and M1-selective muscarinic antagonists before ECT.
    Levine J; Swartz M; Feibel H; Schreiber G
    Isr J Psychiatry Relat Sci; 1993; 30(3):179-82. PubMed ID: 8225935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.